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An outbreak of community-associated USA300 methi-
cillin-resistant Staphylococcus aureus occurred in a beauti-
cian and 2 of her customers. Eight other persons, who were 
either infected (n = 5) or colonized (n = 3), were linked to 
this outbreak, including a family member, a household con-
tact, and partners of customers. 
The reported number of community-associated meth-icillin-resistant Staphylococcus aureus (CA-MRSA) 
infections is increasing rapidly. CA-MRSA is increasingly 
isolated from patients who lack traditional risk factors for 
colonization or infection. CA-MRSA often contains the 
virulence factor Panton-Valentine leukocidin (PVL), which 
causes skin and soft tissue infections. 
The CA-MRSA USA300 strain is known to cause 
outbreaks among population groups (1), such as native 
Americans, prison inmates, military personnel, men who 
have sex with men, and competitive sports participants, and 
accounts for 97% of MRSA isolates obtained in emergency 
departments across the United States from patients with 
soft tissue infections (2). CA-MRSA is associated with in-
vasive infections, including necrotizing fasciitis (3), sepsis 
(4), and pneumonia (5). The USA300 strain, which is also 
found in Europe (6), was fi rst isolated in the Netherlands 
in 2002.
Overall prevalence of MRSA in the Netherlands is low 
(2%) (7). In 2006, 3.8% (n = 76) of all MRSA isolates (1 
per patient) sent to the National Institute for Public Health 
were identifi ed as the USA300 strain. We report an out-
break of the USA300 strain related to a beauty salon in the 
Netherlands, in a beautician, a family member, a household 
contact, and customers and their partners.
The Study
In September 2005, a medical microbiologist from the 
regional medical microbiology laboratory reported to the 
municipal health department a recurring MRSA infection 
in a beautician. From December 2004 onwards, the woman 
had recurrent infections on the legs, buttocks, and groin re-
sulting in incision and drainage of lesions. When an abscess 
developed in the genital area in July 2005, MRSA was cul-
tured from a wound swab. In December 2005, the beau-
tician was declared MRSA-free after antimicrobial treat-
ment. Swabs were taken 3 times in 1-week intervals from 
nose, throat, perineum, and wound and used for enrichment 
culture of MRSA. In March 2006, the woman was tested 
again for MRSA colonization; test results showed that she 
had been reinfected or that therapy had failed. The beauti-
cian also had eczema. Because of the “hands on” nature of 
her work, she was advised to temporarily stop providing 
services to customers. 
The municipal health department conducted a risk 
assessment of the woman’s household contacts and the 
beauty salon. The Netherlands does not require that MRSA 
infections be reported. Therefore, the municipal health de-
partment depends upon the consent and full cooperation 
of index patients and contacts for further investigation of 
outbreaks. Consequently, in this instance, household con-
tacts for screening were identifi ed but had not presented 
themselves for screening. Contacts who had complaints 
sought treatment at the emergency department, where the 
observant infection control practitioner (ICP) and micro-
biologists related them to the MRSA outbreak. Nurses ob-
tained specimens by swabbing each patient’s nose, throat, 
and wounds. A case was defi ned as a patient who had a 
culture-confi rmed MRSA infection during the outbreak pe-
riod July 2005–December 2006 and a direct epidemiologic 
link to the index patient.
In April 2006, a salon customer was hospitalized with 
an abscess of the breast caused by MRSA; in July 2006, 
another customer who had had boils since February 2006 
was found to be MRSA positive. Both customers had been 
given wax treatments by the beautician during the period in 
which she had an infected hair follicle in her armpit. Swabs 
taken from this site showed that the beautician was infected 
with the same MRSA strain as before. Concern arose about 
the risk for infection to customers through instruments, ma-
terials (wax), or contact with other employees. The index 
patient and the other 6 employees of the salon regularly 
provided services to each another.
A nurse and ICP of the municipal health department 
visited the salon in June 2006 to check on hygiene proto-
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cols and to advise on preventive measures to reduce risk for 
further transmission. All working procedures and protocols 
were investigated, and the salon was advised to clean and 
disinfect instruments and procedure rooms. More specifi -
cally, the ICP observed a total waxing procedure performed 
by the staff. Ten swabs were taken from used wax, wax 
implements, and the treatment room. All 6 employees were 
screened and informed about MRSA and the current situa-
tion. Arrangements were also made to test 22 regular cus-
tomers who had received wax treatments by the index pa-
tient in the previous 2 months. In the following weeks, these 
customers were screened at the municipal health offi ce and 
informed about MRSA. Of the 22 regular customers, 21 
completed a questionnaire and 19 were actually screened 
for MRSA by culturing samples from nares and throats.
All employees and the 19 selected regular customers 
were negative for MRSA colonization. All environmental 
swabs were also negative for MRSA. It was noted that the 
70% alcohol used to disinfect the skin after waxing was 
diluted with water because customers had complained 
about the stinging effect of the alcohol on treated skin. Fur-
thermore, it became apparent that after performing wax-
ing treatments the beautician would touch the waxed skin 
of customers with ungloved hands to check for remain-
ing hairs. She did not wash her hands after removing the 
gloves.
During the outbreak investigation, more background 
information became available from those who were MRSA 
colonized or infected and who could be indirectly linked 
to the beautician or her customers. During the week that 
the fi rst infected customer was identifi ed (in April 2006), 
another customer was hospitalized with an abscess in the 
groin. Unfortunately, no culture was taken from this pa-
tient. The partner of the second infected customer was also 
infected with MRSA that was related to an abscess on his 
leg. By the end of 2006, a MRSA-positive couple was iden-
tifi ed as a contact of the second infected customer. In Au-
gust 2006 another couple was reported to be MRSA posi-
tive; both had abscesses on the thighs. Because no further 
epidemiologic data could be obtained, whether the couple’s 
infection was linked to the beauty salon is not clear. 
A total of 45 persons who had been in direct or indi-
rect contact with the beautician were screened for MRSA: 3 
family members, 3 roommates, 11 other persons (including 
secondary contacts), 6 beauty salon employees, and 22 cus-
tomers (including regular customers). Fifteen persons had 
skin infections and 10 of them were colonized with MRSA 
(beautician, family member, roommate, ex-partner of the 
roommate, customers, and partners of customers). Al-
though skin infections never developed in the beautician’s 
family members, tests did show MRSA colonization in one 
of them. The beautician’s boyfriend, a native of the United 
States, had already lived for >2 years in the Netherlands. 
Although he had skin lesions, no S. aureus was found. The 
girlfriend of a sport mate who regularly exercised with the 
partner of a customer was colonized with MRSA at the 
end of 2006. She had immigrated recently from the United 
States to the Netherlands, but her fi rst screening test results 
were negative. The mean age of the patients was 29 years 
(range 21–40 years).
Eleven people were found to be MRSA positive. Of 
these 11, 3 persons with a direct link to the beauty salon 
(the beautician and 2 customers) (Table), 6 with an indirect 
link (family member, roommate, ex-partner of roommate, 
partner of a customer, sport mate of partner of a customer 
and his partner), and a couple from whom no epidemio-
logic data could be obtained were infected with the same 
MRSA strain as the beautician. To characterize the MRSA 
isolates, the following typing methods were used: pulsed-
fi eld gel electrophoresis (PFGE), staphylococcal protein A 
(spa) typing, multilocus sequence typing, staphylococcal 
cassette chromosome mec (SCCmec) typing, PCR for PVL 
genes (LukS-LukF), and a recently described assay for the 
USA300 strain-specifi c arginine catabolic mobile element 
(ACME)–encoded arcA gene (8). 
All MRSA isolates were identical and identifi ed as the 
well-known CA-MRSA USA300 strain. All strains were 
PFGE type 218 (according to the Dutch PFGE classifi cation 
system = USA300), spa type t024, sequence type (ST)8 (1 
isolate was characterized as ST879, a singleton of ST8), 
SCCmec IVa, and positive for PVL and ACME. All MRSA 
isolates had identical susceptibility patterns: resistant to 
oxacillin (and thus to all β-lactam antimicrobial drugs) and 
erythromycin, and susceptible to rifampicin, ciprofl oxacin, 
gentamicin, clindamycin, vancomycin, teicoplanin, tetra-
cycline, cotrimoxazole, mupirocin, and fusidic acid. 
Conclusions
Outbreaks of CA-MRSA strains have been reported 
with increased frequency. Several reports involved out-
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Table. Characteristics of MRSA outbreak related to a beauty salon, the Netherlands* 
Case no. Case-patient Age, y Gender Type of infection Site of infection 
Date of first positive 
MRSA culture 
MRSA sample 
test results 
1 Beautician, index 21 F Abscess Leg, buttock, groin 2005 Jul W+
2 Customer no. 1† 36 F Abscess Breast 2006 Mar W+
3 Customer no. 2 29 F Boils, abscess Genitals 2006 Jul N+, T+, P+, W+ 
*MRSA, methicillin-resistant Staphylococcus aureus; W, wound; N, nose; T, throat; P, perineum; +, positive.  
†Hospitalized.
MRSA in a Beauty Salon
breaks among competitive sports participants, military 
personnel, men who have sex with men, prisoners, native 
Americans, and drug users (1,9,10). Skin treatments in a 
beauty salon likely led to MRSA transmission as a result of 
contact with an infected beautician.
Clearly, our study and others show that CA-MRSA 
is an emerging problem in the community setting. In the 
Netherlands, patients are generally only tested after recur-
rent infections. Unless outbreaks occur in a defi ned group, 
MRSA remains undetected in the general population be-
cause reporting is not mandatory. Although the prevalence 
of MRSA in the Netherlands is low, local microbiologic 
laboratories should report outbreaks, when detected, to the 
local municipal health department for further investigation. 
More research is necessary to better understand the risk 
factors involved in these outbreaks.
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